Skinoren is a topical cream containing Azelaic Acid, which we use to treat both acne vulgaris & rosacea.
Results are usually seen after 4 weeks of treatment, although this may differ in more severe cases. Treatment should not be used for longer than 12 months.
Before applying Skinoren cream, the affected skin should be thoroughly washed with plain water and dried (a mild skin-cleansing agent can be used).
The active ingredient in Skinoren cream is Azelaic acid. Each gram of Skinoren cream contains 200mg of Azelaic Acid (20% w/w).
For a full list of additional ingredients (excipients), click here for the patient information leaflet.
What conditions can Skinoren cream be used for?
Skinoren Cream is used to treat common acne, otherwise known as acne vulgaris and some forms of rosacea. The cream works by attacking the bacteria (Propionibacterium acnes) which play a vital role in causing the conditions to develop.
Additionally, Skinoren creams slows the growth rate of the outmost hard skin cells which can block pores and cause blackheads and whiteheads to form.
How to use Skinoren cream
Skinoren Cream should be used in accordance with your prescriber's instructions.
Normally the cream is applied to the affected skin twice daily (morning and night). As a general guide 0.5g (approx. 2.5cm) of cream is sufficient to treat the entire facial area. Patients with sensitive skin should apply the cream once daily in the evenings for the first week before increasing up to twice daily.
Before applying the cream, the affected skin should be thoroughly washed with plain water and dried (a mild skin-cleansing agent can be used).
Depending on the severity of the condition, the duration of treatment will vary from patient to patient. Results are normally apparent after 4 weeks of use, with most patients requiring several months of treatment to achieve the best results.
The cream should not be used for longer than 12 months. For a copy of the patient information leaflet click here.
Who cannot use Skinoren cream
Skinoren should not be used by anyone with a known or suspected allergic reaction to Azelaic Acid or any of its known excipients.
Skinoren Cream is intended to be used in adults and children over the age of 12. The efficacy in those under the age of 12 has not established and therefore the cream should be avoided in this patient group.
No targeted studies have been performed in these over the age of 65, those with renal impairment or those with hepatic impairment. Use of Skinoren Cream and these patients should be with caution and only where the potential benefits outweigh the risks.
For a full summary of the product characteristics, clicking here
Pregnancy and breastfeeding
There are no adequately controlled studies on the effects of topical Azelaic Acid in pregnant females. Animal studies have shown the potential for developmental effects on the embryo but the concentration in these studies was much greater than the maximum daily dose in humans. Azelaic Acid should be prescribed with extreme caution to pregnant females.
Infants should not come into contact with skin that has been treated with Azelaic Acid. Again, is it not known if Azelaic Acid passes into breast milk, but due to its relatively low absorption rate through the skin, the levels which could potentially reach the breastmilk would be too low to cause any harm. Caution should be taken if prescribing Skinoren Cream to a breastfeeding mother.
Click here for the full product summary.
Like all medication, Skinoren Cream can sometimes cause unwanted side effects to occur.
Very Common - Localised skin reactions (burning, itching, redness) at the site of administration.
Common - skin dryness, scaling, localised pain, skin discolouration and irritation at site of application.
Uncommon - loss of skin colour, acne worsening, tingling, dermatitis, discomfort at the site of application.
Rare - vesicles developing, ulcers, eczema, allergic reactions
Side effects should be reported to your prescriber as they may recommend discontinuing treatment depending on the severity of the side effects.
For a full list of side effects, please refer to the patient information leaflet.